Across TCGA pan-cancer cohorts, RNU6-590P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-590P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU6-590P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-590P expression acts as an unfavorable survival marker.

PAAD and STAD are the cancer types where RNU6-590P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.100	0.614	<.001	72	view →
STAD	OS	Tertile	All	0.061	0.731	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNU6-590P tumor-vs-normal RNA expression · all RNU6-590P data types